Regarding the preoperative Hb rate, cancer patients’ quality of life is substantially impacted by anemia [19], and many patients are anemic following chemotherapy, surgery, or even bleeding tumors, metastasis, or inflammatory status [20]. This evidence concerns the gene GSTM1 and anemia.